Danaher Corporation $DHR Position Boosted by Avalon Trust Co

Avalon Trust Co lifted its holdings in Danaher Corporation (NYSE:DHR) by 5.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 78,807 shares of the conglomerate’s stock after purchasing an additional 3,847 shares during the period. Danaher comprises 1.0% of Avalon Trust Co’s holdings, making the stock its 26th biggest holding. Avalon Trust Co’s holdings in Danaher were worth $15,624,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. WFA of San Diego LLC acquired a new position in Danaher in the second quarter worth approximately $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher during the 2nd quarter worth $27,000. ANTIPODES PARTNERS Ltd acquired a new position in shares of Danaher in the 3rd quarter worth $27,000. TruNorth Capital Management LLC acquired a new stake in shares of Danaher during the third quarter worth $28,000. Finally, Tripletail Wealth Management LLC purchased a new stake in shares of Danaher during the third quarter valued at $31,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Down 0.8%

Danaher stock opened at $209.56 on Monday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $242.80. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The stock has a market cap of $148.02 billion, a P/E ratio of 41.58, a P/E/G ratio of 2.83 and a beta of 0.91. The company’s fifty day simple moving average is $226.85 and its 200-day simple moving average is $216.03.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. During the same period last year, the company earned $2.14 earnings per share. Danaher’s quarterly revenue was up 4.6% compared to the same quarter last year. As a group, sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were paid a dividend of $0.32 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 25.40%.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of analyst reports. JPMorgan Chase & Co. lifted their price target on Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Evercore reissued an “outperform” rating and issued a $254.00 target price on shares of Danaher in a research report on Wednesday, January 28th. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a report on Monday, December 29th. Jefferies Financial Group raised their price objective on shares of Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Finally, KeyCorp reiterated an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. Twenty research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $253.86.

Insider Activity

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 11.20% of the stock is currently owned by corporate insiders.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.